Content by user

Recommend an ISMP Fellowship

If you have a pharmacy resident or know someone who is interested in medication safety or becoming a medication safety officer, recommend that they become an ISMP Safe Medication Management Fellow or ISMP/FDA Safe Medication Management Fellow. In doing so, they will spend a year working at ISMP with some of the nation’s top leaders in error prevention and safe medication use methods, and receive the best training they will need for that medication safety role. Applications for the 2018-2019 fellowships are due March 31, 2018. For more information and to apply, go to: http://www.ismp.org/profdevelopment/default.aspx

ISMP Educational Events

Don’t Miss Next Practitioner in Residence Session, March 5-9, 2018 

Healthcare professionals can spend a one-week “rotation” at ISMP’s office in suburban Philadelphia, PA, to train directly with national experts. Participants learn to use a unique model for identifying and controlling risk, and can also get help with specific organizational challenges and planning high-leverage safety initiatives. Spaces for the March rotation are going fast, so sign up soon. To learn more or to enroll in a session, call Michelle Mandrack, MSN, RN at 215-947-7797.

Register for a 2018 MSI Workshop

The last Medication Safety Intensive Workshop (MSI) sold out quickly! Act now to avoid being put on the waiting list for 2018—you won’t want to miss this unique opportunity to maximize your organization's error prevention efforts. To register: www.ismp.org/sc?id=637

February MSOS Member Briefing Webinar

Sign up now for the next quarterly MSOS Member Briefings webinar scheduled to be held on Thursday, February 22, 2018 from 1:00-2:00 pm EST. Topics will include:

  • Expanding the Use of Capnography to Monitor High Risk Opioid Patients
    • Safe Use of EPINEPhrine
  • Meeting the New ISMP Best Practice: Eliminating Injectable Promethazine
  • ISMP update.

This free webinar has limited attendance and is restricted to MSOS members. For registration information, go to: https://register.gotowebinar.com/register/3875384151275245570

Two February Dates You Don't Want to Miss

High Alert Self Assessment Deadline: February 28, 2018

Healthcare facilities that would like to participate in the first ISMP Medication Safety Self Assessment for High-Alert Medications must submit their data by February 28, 2018. This is a unique opportunity to evaluate your best practices related to high-alert medications and obtain weighted scores to compare with demographically similar organizations. Participation can also help meet requirements for managing high-alert medications from regulatory and accrediting agencies. To access the self assessment workbook, go to: www.ismp.org/selfassessments/SAHAM/Default.aspx

Don't Miss February Just Culture Certification Course  

Time is running out to register for Outcome Engenuity (OE) and ISMP's Medication Safety Focused Just Culture Certification Course, being offered February 21-22 in Phoenix, AZ. Learn how to lead your organization through a culture transformation, which is essential for effective error prevention, and receive a subscription to the Just Culture Assessment Tool. Sign up with  ISMP's discount code (ISMP2018) to receive $200 off registration. For more information, visit: www.ismp.org/sc?id=3040.

If you have more than one concentration of PCA for the same medication, how do you safeguard from incorrect concentration selections in the pump:

Have you eliminated injectable promethazine?

ISMP is looking for organizations that have fully implemented the new ISMP Targeted Medication Safety Best Practices for Hospitals #13 (below).  If you are able to share your experience(s), please contact Allen Vaida at avaida@ismp.org

#13- Eliminate injectable promethazine from the hospital.

  • Remove injectable promethazine from all areas of the hospital including the pharmacy.
  • Classify injectable promethazine as a non-stocked, non-formulary medication.
  • Implement a medical staff-approved automatic therapeutic substitution policy to convert all injectable promethazine orders to another antiemetic.
  • Remove injectable promethazine from all computerized medication order screens, and from all order sets and protocols.

Pages